Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.


Ensuring manufacturing continuity during the pandemic

Ensuring manufacturing continuity during the pandemic. Together.

‘Make it better together’ is a guiding tenet for how we operate each day. Yet, as it often does during a crisis, a truly collaborative effort during the present pandemic involving all our supply partners, airline & shipping companies, freight forwarders, transporters and our own cross-functional teams, has emphatically reinforced this belief. It has allowed us to keep our supply chain intact ensuring that our manufacturing operations continued with zero downtime and enabled us to uphold our commitments to our customers.

Proactive risk identification
Anticipating the supply chain risk well before COVID-19 was declared a global pandemic, we conducted a survey covering all our partners, especially in the affected countries, to assess the risk and get a granular understanding of the extent of supply impact across various projects. This timely and detailed information helped our supply chain team develop various strategies to mitigate or minimize the impact.

Translating plans to actions
For an intense period of close to ten weeks, all our cross-functional teams and external partners sustained a 24 x 7 operating model spanning various time zones and implementing solutions in real-time. The team shifted all pending orders in highly affected zones to partners located in medium and low impact zones, by leveraging the strong relationships built over time. We also increased the share of supplies from partners located in less impacted regions. Once the materials were ready, their movement posed a considerable challenge. The team had to reroute several shipments adopting complex logistics solutions involving multi-mode, multi-continent and multi 3PL operators. We used all functional entry gateways, both airports and seaports, which were functional for both inbound and outbound shipments.

Gratifying outcome of collaborative effort
The team handled a total of 294 shipments from the start of lockdown, honouring the delivery commitment to the customers with OTIF > 97% while ensuring zero downtime in the manufacturing activity. Most importantly, the entire effort demonstrated the strength and resilience of our relationships, and an unwavering zeal to make it better together.

Share article

More News


Sai Life Silver Jubilee year

Sai Life Sciences enters its Silver Jubilee year; surpasses vision of 25 commercial molecules by 2025

Sai Life Sciences entered its Silver Jubilee year with aplomb, surpassing its vision of supporting global innovator partners in bringing 25 new medicines to market by 2025. The company crossed this milestone two years ahead of schedule and is poised to sustain this momentum on the back of a strong portfolio of molecules at various […]
Read more



Sai Life Sciences joins Science Based Targets initiative (SBTi), commits to fight climate change with Science

To help combat climate change, Sai Life Sciences, a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), announced joining Science Based Targets initiative (SBTi), a global body enabling businesses to set ambitious emission reduction targets in line with the latest climate science. Accordingly, it has committed to set near-term company-wide emission reductions in line with […]
Read more


Commitment to Sustainability

Sai Life Sciences reaffirms commitment to Sustainability, charts out SDGs to be achieved by FY27

On the World Environment Day 2023, Sai Life Sciences, a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), announced its renewed Sustainable Development Goals (SDG) charting out the roadmap to achieve specific environmental, social and governance (ESG) targets by the financial year ending March 31, 2027. Making the announcement, Krishna Kanumuri, CEO & Managing Director, […]
Read more


SSRL inauguration

Sai Life Sciences opens SSRL, a dedicated research facility for Schrödinger, at its Hyderabad R&D Campus

• Fully equipped labs with 75-member team set-up and made operational in <100 days Sai Life Sciences, one of India’s fastest growing global Contract Research, Development & Manufacturing Organisations (CRO-CDMO), today announced the opening of Sai Schrödinger Research Laboratories (SSRL) at its R&D campus in Hyderabad, India. The facility was inaugurated by Dr. Karen Akinsanya, […]
Read more


Sai Life Sciences & NIIT Foundation

Sai Life Sciences and NIIT Foundation partner to create livelihood opportunities for underserved communities in Hyderabad

Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRO-CDMO), today announced entering into an agreement with NIIT Foundation, a not-for-profit education society, to implement youth career development programs for underserved communities in Hyderabad, Telangana. As part of the agreement, NIIT Foundation will develop and run multiple courses, and provide […]
Read more